2-Methyl-2,6-diazaspiro[3.3]heptane dihydrochloride, 97%, 5g

(S)-1-((S)-1-Methylpyrrolidin-2-yl)ethan-1-ol, 97%, 1g

5-Bromo-2-(4-methylpiperazin-1-yl)pyrimidine, 95.0%, 1g

1,2,3,6-Tetrahydro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-pyridine, 98%, 5g

2-Oxo-4- p -tolyl-2,3-dihydro-thiazole-5-carboxylic acid ethyl ester, 250mg

3-Nitrophenylacetic Acid>98.0%(T)1g

Methyl 2-amino-5-methoxybenzoate, 95.0%, 5g

3,6-DI-TERT-BUTYL-9-MESITYL-10-PHENYLACRIDIN-10-IUM TETRAFLUOROBORATE, 95%, 10g

1,4-Di(prop-1-yn-1-yl)benzene, 98%, 5g

(S)-3-((Benzyloxy)carbonyl)-2-oxoimidazolidine-4-carboxylic acid, 95.0%, 25g

Morfolina, mínimo 99 %, para síntesis, 2,5 l, envase de vidrio

2-Chloro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 250mg

2-(4-Aminopyrimidin-2-yl)propan-2-ol, 98%, 250mg